Header image

Session 6C: Engineering life: When AI meets quantum in drug discovery

Tracks
Track 3
Thursday, October 22, 2026
1:45 PM - 2:30 PM
Discovery & Advanced Therapeutics Breakout Room

Details

This expert panel will explore the transformative convergence of artificial intelligence and quantum computing in drug discovery, examining how these technologies together could shift medicine from slow, trial-and-error experimentation to predictive, precision-designed therapeutics. Bringing together leaders from AI and quantum computing, biotech, and pharma, the discussion will unpack the scientific breakthroughs enabling molecular simulation at unprecedented accuracy, the potential to dramatically shorten development timelines, and the implications for personalized medicine, rare disease treatment, and pandemic response. The panel will also address critical challenges—including scalability, regulation, and equitable access—to ensure this technological fusion delivers global benefit. Attendees will gain a forward-looking view of how AI and quantum technologies may redefine the future of healthcare and the competitive landscape of the industry.


Speaker

Agenda Item Image
Dr. Kym Baker
General Manager
Thermo Fisher Scientific

Chair

Agenda Item Image
Prof Warwick Bowen
Director
Australian Research Council Centre of Excellence in Quantum Biotechnology (QUBIC)

Panellist

Agenda Item Image
Mr Johann Kruse
Director Strategic Ai Partnerships
NVIDIA

Panellist

Agenda Item Image
Ms Zuzana Leova
PhD Candidate
University of Melbourne based at Melbourne Integrative Genomics (MIG) and the ARC Centre of Excellence in Quantum Biotec

Panellist

Agenda Item Image
Mr Rob Lindwall
Head of Business Operations
PsiQuantum Australia

Panellist

Agenda Item Image
Dr Benham Tonekaboni
Lead Quantum Software Engineer
Infleqtion

Panellist

loading